Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135514 | 1.00 | FFAR4 (0.59) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL1962661 | 0.93 | FFAR4 (0.67) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL6135273 | 0.93 | FFAR4 (0.67) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL8002202 | 0.91 | FFAR4 (0.65) | FFAR4FFAR1GPR84PPARGPPARD | |
| Stearic Acid SCHEMBL27442953 | 0.88 | FFAR4 (0.61) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL26503035 | 0.88 | CA2 (0.50) | TSHRALDH1A1KMT2AMEN1HSD17B10 | |
| SCHEMBL29109109 | 0.87 | FFAR4 (0.59) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL9501494 | 0.86 | CES2 (0.59) | FFAR4FFAR1 | |
| SCHEMBL5027732 | 0.86 | CES2 (0.59) | FFAR4FFAR1 | |
| SCHEMBL22016019 | 0.86 | CES2 (0.59) | FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024136261-A1 | ANTI-INFLAMMATORY OR ANTIOXIDANT COMPOSITION COMPRISING BENZYL CAFFEATE AS ACTIVE INGREDIENT | 동아대학교 산학협력단 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024136517-A1 | COMPOSITION CONTAINING STURGEON MUCILAGE AS ACTIVE INGREDIENT FOR WOUND HEALING OR ACNE TREATMENT | 순천향대학교 산학협력단 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024136513-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH, COMPRISING STURGEON MUCUS AS ACTIVE INGREDIENT | 주식회사 에셀바이오팜 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024128690-A1 | INNATE IMMUNOMODULATORY EFFECT OF GINSENG BERRY POLYSACCHARIDES IN IMMUNOSUPPRESSED STATE | 강릉원주대학교산학협력단 | 2024-06-20 | — | — | WO | disclosed |
| US-20240197672-A1 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2024-06-20 | — | — | US | disclosed |
| US-20240180833-A1 | NANOVESICLES DERIVED FROM BACTERIA OF THE GENUS PARACOCCUS AND USE THEREOF | MD HEALTHCARE INC. (KR) | 2024-06-06 | — | — | US | disclosed |
| CN-117940109-A | Composition for preventing bromhidrosis | 持田制药株式会社 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024085695-A1 | NOVEL ALTIRATINIB DERIVATIVE, MANUFACTURING METHOD THEREFOR, AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SKIN PIGMENTATION | 재단법인 아산사회복지재단 | 2024-04-25 | — | — | WO | disclosed |
| EP-3662907-B1 | ANTI-AGING OR SKIN-REGENERATING COMPOSITION COMPRISING PIPERONYLIC ACID AS EFFECTIVE INGREDIENT | HESED BIO CO LTD (KR) | 2024-04-17 | — | — | EP | disclosed |
| EP-4349353-A1 | LACTOBACILLUS RHAMNOSUS-DERIVED VESICLE AND USES THEREOF | MD Healthcare Inc. (KR) | 2024-04-10 | — | — | EP | disclosed |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | KANEKA CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1689494-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | Showa Denko K.K. (JP) | 2006-08-16 | — | — | EP | disclosed |
| EP-1660025-A1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | Showa Denko K.K. (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005102267-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING TOCOPHEROL DERIVATIVE, ASCORBIC ACID DERIVATIVE AND SURFACE ACTIVE AGENT HAVING LIPOPEPTIDE STRUCTURE | SHOWA DENKO K.K. (JP) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005094777-A1 | EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095462-A1 | MOISTURE RETENTION POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197672-A1 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | TYR, ATG7, BECN1 | FFAR4 4514/4885FFAR1 4168/4885GPR84 3246/4885 |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | CUTA, SMURF1, FABP4 | FFAR4 73/4885FFAR1 22/4885GPR84 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.